GAMT p.Ala56Val

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BP4_Strong

The NM_000156.6(GAMT):​c.167C>T​(p.Ala56Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000258 in 1,513,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A56T) has been classified as Uncertain significance. The gene GAMT is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

GAMT
NM_000156.6 missense

Scores

1
4
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 5.12

Publications

0 publications found
Variant links:
Genes affected
GAMT (HGNC:4136): (guanidinoacetate N-methyltransferase) The protein encoded by this gene is a methyltransferase that converts guanidoacetate to creatine, using S-adenosylmethionine as the methyl donor. Defects in this gene have been implicated in neurologic syndromes and muscular hypotonia, probably due to creatine deficiency and accumulation of guanidinoacetate in the brain of affected individuals. Two transcript variants encoding different isoforms have been described for this gene. Pseudogenes of this gene are found on chromosomes 2 and 13. [provided by RefSeq, Feb 2012]
GAMT Gene-Disease associations (from GenCC):
  • guanidinoacetate methyltransferase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000156.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 19 uncertain in NM_000156.6
BP4
Computational evidence support a benign effect (MetaRNN=0.049428612).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000156.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAMT
NM_000156.6
MANE Select
c.167C>Tp.Ala56Val
missense
Exon 1 of 6NP_000147.1Q14353-1
GAMT
NM_138924.3
c.167C>Tp.Ala56Val
missense
Exon 1 of 5NP_620279.1Q14353-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAMT
ENST00000252288.8
TSL:1 MANE Select
c.167C>Tp.Ala56Val
missense
Exon 1 of 6ENSP00000252288.1Q14353-1
GAMT
ENST00000902474.1
c.167C>Tp.Ala56Val
missense
Exon 1 of 6ENSP00000572533.1
GAMT
ENST00000447102.8
TSL:2
c.167C>Tp.Ala56Val
missense
Exon 1 of 5ENSP00000403536.2Q14353-2

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
152084
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000539
AC:
8
AN:
148380
AF XY:
0.0000236
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000205
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000846
GnomAD4 exome
AF:
0.0000242
AC:
33
AN:
1360962
Hom.:
0
Cov.:
31
AF XY:
0.0000237
AC XY:
16
AN XY:
675424
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
28536
American (AMR)
AF:
0.000422
AC:
15
AN:
35586
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23736
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76346
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35012
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4500
European-Non Finnish (NFE)
AF:
0.0000140
AC:
15
AN:
1068938
Other (OTH)
AF:
0.0000535
AC:
3
AN:
56124
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152196
Hom.:
0
Cov.:
32
AF XY:
0.0000537
AC XY:
4
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41566
American (AMR)
AF:
0.000196
AC:
3
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5144
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67964
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000151

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Cerebral creatine deficiency syndrome (1)
-
1
-
Deficiency of guanidinoacetate methyltransferase (1)
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.033
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.32
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.78
T
M_CAP
Pathogenic
0.59
D
MetaRNN
Benign
0.049
T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
-0.35
N
PhyloP100
5.1
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
0.19
N
REVEL
Uncertain
0.31
Sift
Benign
0.64
T
Sift4G
Benign
1.0
T
PromoterAI
0.038
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.6
Varity_R
0.15
gMVP
0.51
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs575350720;
hg19: chr19-1401309;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.